• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Tuberculosis Global Clinical Trials Review, Q4, 2010 - Product Image

Tuberculosis Global Clinical Trials Review, Q4, 2010

  • ID: 1496284
  • December 2010
  • Region: Global
  • 39 pages
  • GlobalData

Tuberculosis Global Clinical Trials Review, Q4, 2010

Summary

Our clinical trial report, “Tuberculosis Global Global Clinical Trials Review, Q4, 2010"” provides data on the Tuberculosis clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Tuberculosis.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Tuberculosis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Tuberculosis
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Tuberculosis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Otsuka Pharmaceutical Co., Ltd.
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd.
Clinical Trial Overview of Vakzine Projekt Management GmbH
Global Alliance for TB Drug Development
Clinical Trial Overview of Global Alliance for TB Drug Development
Clinical Trial Overview of Abbott Laboratories
Clinical Trial Overview of Archivel Farma S.L.
RIEMSER Arzneimittel AG
Clinical Trial Overview of RIEMSER Arzneimittel AG
Novartis AG
Clinical Trial Overview of Novartis AG
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos